Compare FINW & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FINW | NAUT |
|---|---|---|
| Founded | 1999 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.2M | 245.0M |
| IPO Year | 2021 | N/A |
| Metric | FINW | NAUT |
|---|---|---|
| Price | $17.35 | $2.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 31.3K | ★ 226.6K |
| Earning Date | 01-29-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.51 | N/A |
| EPS | ★ 1.13 | N/A |
| Revenue | ★ $92,093,000.00 | N/A |
| Revenue This Year | $92.23 | N/A |
| Revenue Next Year | $23.28 | N/A |
| P/E Ratio | $15.59 | ★ N/A |
| Revenue Growth | ★ 31.91 | N/A |
| 52 Week Low | $13.49 | $0.62 |
| 52 Week High | $22.49 | $2.54 |
| Indicator | FINW | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 50.92 |
| Support Level | $17.55 | $1.88 |
| Resistance Level | $19.04 | $2.16 |
| Average True Range (ATR) | 0.59 | 0.18 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 6.84 | 53.64 |
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.